Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke

Document Type

Article

Medical Subject Headings

Angiotensin-Converting Enzyme 2; Antibodies, Antiphospholipid (metabolism); Arrhythmias, Cardiac (physiopathology); Betacoronavirus; Brain Ischemia (epidemiology, metabolism, physiopathology, surgery); COVID-19; Conscious Sedation; Coronavirus Infections (epidemiology, metabolism, physiopathology); Endothelium (physiopathology); Fibrin Fibrinogen Degradation Products (metabolism); Humans; Intubation, Intratracheal (methods); Myocardium (metabolism); Pandemics; Peptidyl-Dipeptidase A (metabolism); Pneumonia, Viral (epidemiology, metabolism, physiopathology); Practice Guidelines as Topic; SARS-CoV-2; Stroke (epidemiology, metabolism, physiopathology, surgery); Thrombectomy (methods); Thrombophilia (metabolism, physiopathology)

Publication Date

10-1-2020

Publication Title

World neurosurgery

E-ISSN

1878-8769

Volume

142

First Page

523

Last Page

525

PubMed ID

32987584

Digital Object Identifier (DOI)

10.1016/j.wneu.2020.07.158

Share

COinS